A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting.
Source: News Medical, https://www.news-medical.net/